InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Rothenberg Mace. Director active across 1 company, notably Tango Therapeutics, Inc.. Aggregated, 4 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €34k. History available since 6 June 2023. The latest transaction was disclosed on 5 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Rothenberg Mace is a declarant linked to Tango Therapeutics, Inc. (XNAS), where he is a Director. He has 4 filings in total. In the 4 most recent filings we hold, buys amount to EUR 34267 and sells to EUR 0, over the period from 2023-06-08 to 2025-06-09, and the modal transaction nature is Attribution.